Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
CDSCO Reviews Mercury Antiseptic Exemptions and Pharma Machinery Disposal Rules

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

CDSCO Reviews Mercury Antiseptic Exemptions and Pharma Machinery Disposal Rules

Analysed 1 Oct 2026·2 sources analysed·Rajasthan, India·Business
CDSCO Reviews Mercury Antiseptic Exemptions and Pharma Machinery Disposal RulesPreviousNext

The Central Drugs Standard Control Organisation (CDSCO) is reviewing regulatory measures related to pharmaceutical safety. It has sought the Directorate General of Health Services' opinion on maintaining exemptions for mercury-based topical antiseptics like Mercurochrome under Schedule K, which facilitates access in underserved areas. Separately, the CDSCO's advisory panel has requested Rajasthan drug regulators to develop a detailed framework for the supply, decommissioning, and disposal of pharmaceutical machinery to prevent misuse in producing spurious drugs, highlighting concerns over enforcement challenges.

Sentiment
51%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (51/100). Lens Score 60/100.

Outlets measured: businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 1 Oct 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Neutral (51/100)

Sentiment was consistent across outlets (50–52/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

businessstandard broke this story on 1 Oct, 12:56 pm. Other outlets followed.

1 Oct, 12:56 pm2 sources · 51 min1 Oct, 01:47 pm
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
RBI Allows One-Time Approval for Institutional Investors Holding Up to 10% in Banks
Next →
Jio Platforms Expands Tech Business and Prepares for India’s Largest IPO
businessstandard1 Oct, 12:56 pm
Drug regulator may review machinery disposal at non-compliant pharma units
  • 2
    businessstandard1 Oct, 01:47 pm
    CDSCO seeks DGHS view on exemptions for mercury-based topical antiseptics
  • Accountability flags

    TBN's analysis identified the following accountability dimensions in this story.

    • public safety issue

      This story involves a risk to public safety — infrastructure failure, regulatory lapse, hazardous conditions, or emergency mishandling.

    Who's involved

    Institutions and figures named across source coverage.

    Government
    Central Drugs Standard Control OrganisationDrugs Consultative CommitteeRajasthan Drug Control DepartmentNational Human Rights CommissionDirectorate General of Health Services

    Story context

    Category
    Business
    Location
    Rajasthan, India
    Sources analysed
    2
    Last analysed
    1 Oct 2026
    Key entities
    Central Drugs Standard Control OrganisationAntibioticMedicationPatentAnalgesicChief executive officerBusiness StandardIndiaMerbrominAntisepticTopical medicationChronic kidney disease